Gene Mutation Increases Drug Toxicity, Rejection Risk In Pediatric Kidney Transplants, Cincinnati Children’s Hospital Medical Center Study

ScienceDaily (Feb. 20, 2009) — Screening for mutations in a gene that helps the body metabolize a kidney transplant anti-rejection drug may predict which children are at higher risk for side effects, including compromised white blood cell count or organ rejection, according to new research.